Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 723515, 10 pages
http://dx.doi.org/10.1155/2015/723515
Review Article

Fucoxanthin: A Promising Medicinal and Nutritional Ingredient

1School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
2School of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing 100029, China
3Department of Dermatology, The First Hospital of Chinese People’s Liberation Army, Gansu 730030, China
4School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China

Received 4 January 2015; Accepted 4 May 2015

Academic Editor: Avni Sali

Copyright © 2015 Hui Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. S. Kuipers, D. J. de Graaf, M. F. Luxwolda, M. H. A. Muskiet, D. A. J. Dijck-Brouwer, and F. A. J. Muskiet, “Saturated fat, carbohydrates and cardiovascular disease,” The Netherlands Journal of Medicine, vol. 69, no. 9, pp. 372–378, 2011. View at Google Scholar · View at Scopus
  2. F. Beppu, Y. Niwano, T. Tsukui, M. Hosokawa, and K. Miyashita, “Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice,” The Journal of Toxicological Sciences, vol. 34, no. 5, pp. 501–510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Kim, Y.-J. Jung, O.-N. Kwon et al., “A potential commercial source of fucoxanthin extracted from the microalga Phaeodactylum tricornutum,” Applied Biochemistry and Biotechnology, vol. 166, no. 7, pp. 1843–1855, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Englert, T. Bjørnland, and S. Liaaen-Jensen, “1D and 2D NMR study of some allenic carotenoids of the fucoxanthin series,” Magnetic Resonance in Chemistry, vol. 28, no. 6, pp. 519–528, 1990. View at Publisher · View at Google Scholar
  5. M. Hosokawa, T. Okada, N. Mikami, I. Konishi, and K. Miyashita, “Bio-functions of marine carotenoids,” Food Science and Biotechnology, vol. 18, no. 1, pp. 1–11, 2009. View at Google Scholar · View at Scopus
  6. X. Yan, Y. Chuda, M. Suzuki, and T. Nagata, “Fucoxanthin as the major antioxidant in Hijikia fusiformis, a common edible seaweed,” Bioscience, Biotechnology, and Biochemistry, vol. 63, no. 3, pp. 605–607, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. V. M. Dembitsky and T. Maoka, “Allenic and cumulenic lipids,” Progress in Lipid Research, vol. 46, no. 6, pp. 328–375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Achir, V. A. Randrianatoandro, P. Bohuon, A. Laffargue, and S. Avallone, “Kinetic study of β-carotene and lutein degradation in oils during heat treatment,” European Journal of Lipid Science and Technology, vol. 112, no. 3, pp. 349–361, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Zhao, S.-M. Kim, C.-H. Pan, and D. Chung, “Effects of heating, aerial exposure and illumination on stability of fucoxanthin in canola oil,” Food Chemistry, vol. 145, pp. 505–513, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. R. K. Sangeetha, N. Bhaskar, and V. Baskaran, “Comparative effects of beta-carotene and fucoxanthin on retinol deficiency induced oxidative stress in rats,” Molecular and Cellular Biochemistry, vol. 331, no. 1-2, pp. 59–67, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M.-N. Woo, S.-M. Jeon, H.-J. Kim et al., “Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL/6N mice,” Chemico-Biological Interactions, vol. 186, no. 3, pp. 316–322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. H. J. Park, M. K. Lee, Y. B. Park, Y. C. Shin, and M. S. Choi, “Beneficial effects of Undaria pinnatifida ethanol extract on diet-induced-insulin resistance in C57BL/6J mice,” Food and Chemical Toxicology, vol. 49, no. 4, pp. 727–733, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M.-N. Woo, S.-M. Jeon, Y. C. Shin, M.-K. Lee, M. A. Kang, and M.-S. Choi, “Anti-obese property of fucoxanthin is partly mediated by altering lipid-regulating enzymes and uncoupling proteins of visceral adipose tissue in mice,” Molecular Nutrition & Food Research, vol. 53, no. 12, pp. 1603–1611, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S.-M. Jeon, H.-J. Kim, M.-N. Woo et al., “Fucoxanthin-rich seaweed extract suppresses body weight gain and improves lipid metabolism in high-fat-fed C57BL/6J mice,” Biotechnology Journal, vol. 5, no. 9, pp. 961–969, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Hu, Y. Li, C. Li et al., “Combination of fucoxanthin and conjugated linoleic acid attenuates body weight gain and improves lipid metabolism in high-fat diet-induced obese rats,” Archives of Biochemistry and Biophysics, vol. 519, no. 1, pp. 59–65, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. W. Ha and W. K. Kim, “The effect of fucoxanthin rich power on the lipid metabolism in rats with a high fat diet,” Nutrition Research and Practice, vol. 7, no. 4, pp. 287–293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Maeda, M. Hosokawa, T. Sashima, K. Murakami-Funayama, and K. Miyashita, “Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model,” Molecular Medicine Reports, vol. 2, no. 6, pp. 897–902, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Ntambi and Y. C. Kim, “Adipocyte differentiation and gene expression,” Journal of Nutrition, vol. 130, no. 12, pp. 3122–3126, 2000. View at Google Scholar · View at Scopus
  19. S.-I. Kang, H.-C. Ko, H.-S. Shin et al., “Fucoxanthin exerts differing effects on 3T3-L1 cells according to differentiation stage and inhibits glucose uptake in mature adipocytes,” Biochemical and Biophysical Research Communications, vol. 409, no. 4, pp. 769–774, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Maeda, M. Hosokawa, T. Sashima, N. Takahashi, T. Kawada, and K. Miyashita, “Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells,” International Journal of Molecular Medicine, vol. 18, no. 1, pp. 147–152, 2006. View at Google Scholar · View at Scopus
  21. M.-J. Yim, M. Hosokawa, Y. Mizushina, H. Yoshida, Y. Saito, and K. Miyashita, “Suppressive effects of amarouciaxanthin A on 3T3-L1 adipocyte differentiation through down-regulation of PPARγ and C/EBPα mRNA expression,” Journal of Agricultural and Food Chemistry, vol. 59, no. 5, pp. 1646–1652, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Maeda, M. Hosokawa, T. Sashima, K. Funayama, and K. Miyashita, “Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues,” Biochemical and Biophysical Research Communications, vol. 332, no. 2, pp. 392–397, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. S. I. Kang, H. S. Shin, H. M. Kim et al., “Petalonia binghamiae extract and its constituent fucoxanthin ameliorate high-fat diet-induced obesity by activating AMP-activated protein kinase,” Journal of Agricultural and Food Chemistry, vol. 60, no. 13, pp. 3389–3395, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Pelleymounter, M. J. Cullen, M. B. Baker et al., “Effects of the obese gene product on body weight regulation in ob/ob mice,” Science, vol. 269, no. 5223, pp. 540–543, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Abidov, Z. Ramazanov, R. Seifulla, and S. Grachev, “The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat,” Diabetes, Obesity and Metabolism, vol. 12, no. 1, pp. 72–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. L. Smith, I. T. Chen, Q. Zhan et al., “Interaction of the p53-regulated protein gadd45 with proliferating cell nuclear antigen,” Science, vol. 266, no. 5189, pp. 1376–1380, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Ji, R. Liu, T. Tong et al., “Gadd45a regulates β-catenin distribution and maintains cell-cell adhesion/contact,” Oncogene, vol. 26, no. 44, pp. 6396–6405, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Yoshiko and N. Hoyoko, “Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells,” In Vivo, vol. 21, no. 2, pp. 305–309, 2007. View at Google Scholar · View at Scopus
  29. Y. Satomi and H. Nishino, “Implication of mitogen-activated protein kinase in the induction of G1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells,” Biochimica et Biophysica Acta, vol. 1790, no. 4, pp. 260–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. K.-N. Kim, G. Ahn, S.-J. Heo et al., “Inhibition of tumor growth in vitro and in vivo by fucoxanthin against melanoma B16F10 cells,” Environmental Toxicology and Pharmacology, vol. 35, no. 1, pp. 39–46, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. R. X. Yu, X. M. Hu, S. Q. Xu, Z. J. Jiang, and W. Yang, “Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway,” European Journal of Pharmacology, vol. 657, no. 1–3, pp. 10–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Rengarajan, P. Rajendran, N. Nandakumar, M. P. Balasubramanian, and I. Nishigaki, “Cancer preventive efficacy of marine carotenoid fucoxanthin: cell cycle arrest and apoptosis,” Nutrients, vol. 5, no. 12, pp. 4978–4989, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. C. B. Thompson, “Apoptosis in the pathogenesis and treatment of disease,” Science, vol. 267, no. 5203, pp. 1456–1462, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. L. A. Smets, “Programmed cell death (apoptosis) and response to anti-cancer drugs,” Anti-Cancer Drugs, vol. 5, no. 1, pp. 3–9, 1994. View at Google Scholar · View at Scopus
  35. J. I. Song and J. R. Grandis, “STAT signaling in head and neck cancer,” Oncogene, vol. 19, no. 21, pp. 2489–2495, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Berclaz, H. J. Altermatt, V. Rohrbach, A. Siragusa, E. Dreher, and P. D. Smith, “EGFR dependent expression of STAT3 (but not STAT1) in breast cancer,” International Journal of Oncology, vol. 19, no. 6, pp. 1155–1160, 2001. View at Google Scholar · View at Scopus
  37. K. M. Quesnelle, A. L. Boehm, and J. R. Grandis, “STAT-mediated EGFR signaling in cancer,” Journal of Cellular Biochemistry, vol. 102, no. 2, pp. 311–319, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Wang, S. Chen, S. Xu et al., “In vivo induction of apoptosis by fucoxanthin, a marine carotenoid, associated with down-regulating STAT3/EGFR signaling in sarcoma 180 (S180) xenografts-bearing mice,” Marine Drugs, vol. 10, no. 9, pp. 2055–2068, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Yamamoto, C. Ishikawa, H. Katano, T. Yasumoto, and N. Mori, “Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas,” Cancer Letters, vol. 300, no. 2, pp. 225–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. L. A. Campfield and F. J. Smith, “The pathogenesis of obesity,” Bailliere's Best Practice & Clinical Endocrinology & Metabolism, vol. 13, no. 1, pp. 13–30, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. A.-H. Harding, L. A. Sargeant, A. Welch et al., “Fat consumption and HbA1c levels: the EPIC-norfolk study,” Diabetes Care, vol. 24, no. 11, pp. 1911–1916, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. D. E. Goldstein, R. R. Little, R. A. Lorenz, J. I. Malone, D. Nathan, and C. M. Peterson, “Tests of glycemia in diabetes,” Diabetes Care, vol. 18, no. 6, pp. 896–909, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, “Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance,” Science, vol. 259, no. 5091, pp. 87–91, 1993. View at Publisher · View at Google Scholar · View at Scopus
  44. G. S. Hotamisligil, P. Arner, J. F. Caro, R. L. Atkinson, and B. M. Spiegelman, “Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance,” The Journal of Clinical Investigation, vol. 95, no. 5, pp. 2409–2415, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Nomura, M. Kikuchi, A. Kubodera, and Y. Kawakami, “Proton-donative antioxidant activity of fucoxanthin with 1,1-diphenyl-2-picrylhydrazyl (DPPH),” Biochemistry and Molecular Biology International, vol. 42, no. 2, pp. 361–370, 1997. View at Google Scholar · View at Scopus
  46. A. W. Ha, S. J. Na, and W. K. Kim, “Antioxidant effects of fucoxanthin rich powder in rats fed with high fat diet,” Nutrition Research and Practice, vol. 7, no. 6, pp. 475–480, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. S.-J. Lee, S.-K. Bai, K.-S. Lee et al., “Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NF-κB activation,” Molecules and Cells, vol. 16, no. 1, pp. 97–105, 2003. View at Google Scholar · View at Scopus
  48. K.-N. Kim, S.-J. Heo, W.-J. Yoon et al., “Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-κB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages,” European Journal of Pharmacology, vol. 649, no. 1–3, pp. 369–375, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Sakai, T. Sugawara, K. Matsubara, and T. Hirata, “Inhibitory effect of carotenoids on the degranulation of mast cells via suppression of antigen-induced aggregation of high affinity IgE receptors,” The Journal of Biological Chemistry, vol. 284, no. 41, pp. 28172–28179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Maeda, T. Tsukui, T. Sashima, M. Hosokawa, and K. Miyashita, “Seaweed carotenoid, fucoxanthin, as a multi-functional nutrient,” Asia Pacific Journal of Clinical Nutrition, vol. 17, no. 1, pp. 196–199, 2008. View at Google Scholar · View at Scopus
  51. T. Tsukui, K. Konno, M. Hosokawa, H. Maeda, T. Sashima, and K. Miyashita, “Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice,” Journal of Agricultural and Food Chemistry, vol. 55, no. 13, pp. 5025–5029, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Tsukui, N. Baba, M. Hosokawa, T. Sashima, and K. Miyashita, “Enhancement of hepatic docosahexaenoic acid and arachidonic acid contents in C57BL/6J mice by dietary fucoxanthin,” Fisheries Science, vol. 75, no. 1, pp. 261–263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. C.-L. Liu, A.-L. Liang, and M.-L. Hu, “Protective effects of fucoxanthin against ferric nitrilotriacetate-induced oxidative stress in murine hepatic BNL CL.2 cells,” Toxicology in Vitro, vol. 25, no. 7, pp. 1314–1319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Ikeda, A. Kitamura, H. Machida et al., “Effect of Undaria pinnatifida (Wakame) on the development of cerebrovascular diseases in stroke-prone spontaneously hypertensive rats,” Clinical and Experimental Pharmacology and Physiology, vol. 30, no. 1-2, pp. 44–48, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Aman, A. Schieber, and R. Carle, “Effects of heating and illumination on trans−cis isomerization and degradation of β-carotene and lutein in isolated spinach chloroplasts,” Journal of Agricultural and Food Chemistry, vol. 53, no. 24, pp. 9512–9518, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. L. K. Henry, G. L. Catignani, and S. J. Schwartz, “Oxidative degradation kinetics of lycopene, lutein, and 9-cis and all-trans β-carotene,” Journal of the American Oil Chemists' Society, vol. 75, no. 7, pp. 823–829, 1998. View at Publisher · View at Google Scholar · View at Scopus
  57. B. H. Chen and J. H. Huang, “Degradation and isomerization of chlorophyll a and β-carotene as affected by various heating and illumination treatments,” Food Chemistry, vol. 62, no. 3, pp. 299–307, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Kawee-ai, A. Kuntiya, and S. M. Kim, “Anticholinesterase and antioxidant activities of fucoxanthin purified from the microalga Phaeodactylum tricornutum,” Natural Product Communications, vol. 8, no. 10, pp. 1381–1386, 2013. View at Google Scholar · View at Scopus
  59. A. Asai, T. Sugawara, H. Ono, and A. Nagao, “Biotransformation of fucoxanthinol into amarouciaxanthin a in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites,” Drug Metabolism and Disposition, vol. 32, no. 2, pp. 205–211, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Hashimoto, Y. Ozaki, M. Taminato et al., “The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice,” British Journal of Nutrition, vol. 102, no. 2, pp. 242–248, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Yonekura, M. Kobayashi, M. Terasaki, and A. Nagao, “Keto-carotenoids are the major metabolites of dietary lutein and fucoxanthin in mouse tissues,” The Journal of Nutrition, vol. 140, no. 10, pp. 1824–1831, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Mordenti, “Man versus beast: pharmacokinetic scaling in mammals,” Journal of Pharmaceutical Sciences, vol. 75, no. 11, pp. 1028–1040, 1986. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Hashimoto, Y. Ozaki, M. Mizuno et al., “Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of kombu extract,” British Journal of Nutrition, vol. 107, no. 11, pp. 1566–1569, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. H. Maeda, M. Hosokawa, T. Sashima, and K. Miyashita, “Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice,” Journal of Agricultural and Food Chemistry, vol. 55, no. 19, pp. 7701–7706, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Maeda, M. Hosokawa, T. Sashima, K. Funayama, and K. Miyashita, “Effect of medium-chain triacylglycerols on anti-obesity effect of fucoxanthin,” Journal of Oleo Science, vol. 56, no. 12, pp. 615–621, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. T. Sugawara, M. Kushiro, H. Zhang, E. Nara, H. Ono, and A. Nagao, “Lysophosphatidylcholine enhances carotenoid uptake from mixed micelles by Caco-2 human intestinal cells,” Journal of Nutrition, vol. 131, no. 11, pp. 2921–2927, 2001. View at Google Scholar · View at Scopus
  67. G. Riccioni, N. D'Orazio, S. Franceschelli, and L. Speranza, “Marine carotenoids and cardiovascular risk markers,” Marine Drugs, vol. 9, no. 7, pp. 1166–1175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Kadekaru, H. Toyama, and T. Yasumoto, “Safety evaluation of fucoxanthin purified from Undaria pinnatifida,” Nippon Shokuhin Kagaku Kogaku Kaishi, vol. 55, no. 6, pp. 304–308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. M. C. Zaragozá, D. López, M. P. Sáiz et al., “Toxicity and antioxidant activity in vitro and in vivo of two Fucus vesiculosus extracts,” Journal of Agricultural and Food Chemistry, vol. 56, no. 17, pp. 7773–7780, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Ishikawa, S. Tafuku, T. Kadekaru et al., “Antiadult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol,” International Journal of Cancer, vol. 123, no. 11, pp. 2702–2712, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. E. A. Lew and L. Garfinkel, “Variations in mortality by weight among 750,000 men and women,” Journal of Chronic Diseases, vol. 32, no. 8, pp. 563–576, 1979. View at Publisher · View at Google Scholar · View at Scopus
  72. J. M. Olefsky, R. R. Revers, M. Prince et al., “Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus,” Advances in Experimental Medicine and Biology, vol. 189, pp. 176–205, 1985. View at Google Scholar · View at Scopus